Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05790941

Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation

Proof of Concept of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation for Eyebrows

Sponsor: Aneira Pharma, Inc.

Updated 4 times since 2023 Last updated: Mar 17, 2023 Started: Mar 11, 2023 Primary completion: Jun 30, 2023 Completion: Jun 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05790941, this EARLY_PHASE1 trial focuses on Hypotrichosis and remains ongoing. Sponsored by Aneira Pharma, Inc., it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Mar 2025 — Present [monthly]

Unknown EARLY_PHASE1

Status: Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Recruiting EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting EARLY_PHASE1
Apr 2023 — Jul 2024 [monthly]

Recruiting EARLY_PHASE1

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aneira Pharma, Inc.

Data source: Aneira Pharma, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indian Wells, United States